Operationalizing the Wilson-Jungner principles for the genomics era: Consensus recommendations from the International Consortium on Newborn Sequencing
- PMID: 41765866
- PMCID: PMC12950953
- DOI: 10.1016/j.gim.2025.101618
Operationalizing the Wilson-Jungner principles for the genomics era: Consensus recommendations from the International Consortium on Newborn Sequencing
Abstract
Purpose: For decades, the selection of disorders included in newborn screening (NBS) programs has been guided by principles published by Wilson and Jungner in 1968. As research explores the expansion of conditions included in NBS through genomic sequencing, there is a critical need for updated recommendations to address the opportunities and complexities of genomic data.
Methods: The International Consortium on Newborn Sequencing includes leaders from over 16 research projects investigating genomic NBS across the United Kingdom, Europe, United States, and Oceania. Consortium members were invited to participate in a modified Delphi study, aggregating opinion on the selection of conditions for genomic NBS through 3 rounds of online questionnaires, with feedback provided to participants between rounds.
Results: In round 1, 94 participants completed the questionnaire, and 10 of 43 statements reached consensus. In round 2, 81 participants completed the questionnaire, and 14 of 27 statements reached consensus. In round 3, 68 participants completed the questionnaire, and all 10 statements reached 72% or more consensus.
Conclusion: The 10 consensus recommendations developed in this study can guide future research and public health programs performing genomic NBS. This process also identified key areas of participant discordance, highlighting important topics for future research.
Keywords: Delphi technique; Gene selection; Genomic sequencing; Newborn screening.
Published by Elsevier Inc.
Conflict of interest statement
Conflict of Interest Derek Ansel is a board member for Gene People. Wendy K. Chung is on the board of directors for Prime Medicine. Robert C. Green receives compensation for advising the following companies: Allelica, Atria, Fabric, Genomic Life, and Juniper Genomics; and is a cofounder of Genome Medical and Nurture Genomics. Kristen L. Sund is a consultant at Nurture Genomics. Petros Tsipouras is on the board of directors for PlumCare RWE, Inc. All other authors declare no conflicts of interest.
References
-
- Stark Z, Scott RH. Genomic newborn screening for rare diseases. Nat Rev Genet. 2023;24(11):755–766. - PubMed
-
- Wilson JMG, Jungner G. Principles and Practice of Screening for Diseases. World Health Organization; 1968.
-
- Recommended Uniform Screening Panel. Accessed January 3, 2025. https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp
-
- Kemper Alex R., Ream Margie A., Lam KK. Review of Newborn Screening Implementation for Spinal Muscular Atrophy Final Report. The Health Resources and Services Administration (HRSA). 2020. Accessed December 9, 2024. https://www.hrsa.gov/sites/default/files/hrsa/advisory-committees/herita...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
